Skip to content
Family HoldingAllocates capital directlyActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 10 SOURCES

reference shareholder (50.4% of share capital at 30 June 2026) Foyer Finance SA

Luxembourg-listed, family-controlled investment company (since 1988) taking EUR 25-100m stakes in companies in Benelux, France, DACH and Northern Italy and committing to PE funds.

USEFUL FOR Fund managers raising capital · Business owners seeking a long-term partner · Co-investors

Family & background

HEADQUARTERS
Leudelange, Luxembourg
OFFICES
Paris, France · Munich, Germany
FOUNDED
1988
OUTSIDE CAPITAL
No — own capital only

Investment approach

GEOGRAPHY
LuxembourgBelgiumFranceGermanyItalyNorth America
STAGES
GrowthBuyout
ROUTES
Direct investments · Funds (as LP)
STRATEGIES
Private equityPublic equitiesFunds (as LP)Direct investments

Overview

Luxempart is an investment company listed on the Luxembourg Stock Exchange, based in Leudelange with offices in Paris and Munich, and describes itself as a family-controlled long-term investor. Foyer Finance SA holds 50.4% of its shares and Sofina 6.1% (30 June 2026). It reported a net asset value of about EUR 2.6bn at June 2026 across 27 direct portfolio companies and 68 funds. In December 2025 it agreed to become majority shareholder of German mental-healthcare provider VALEARA and moved to a majority stake in ASSMANN Group.

Investment thesis

Direct equity of EUR 25-100m per line in majority or active minority stakes in private or listed companies in France, DACH, Benelux and Northern Italy, with affinity for financial services and insurance, telecoms, security, healthcare and industrials; plus commitments of USD 10-25m to lower-mid-market buyout and growth funds in Europe and the US.

Holdings & investments (30)

  • Crealis
    Industrial & Manufacturing · since 2020
  • Tonies
    Consumer & E-commerce · since 2019
  • Assmann
    Industrial & Manufacturing · since 2019 · majority (60% after 10% top-up announced Dec 2025)
  • FX Solutions
    HealthTech · since 2017
  • Mirato Group
    Consumer & E-commerce · since 2013
  • Valeara
    HealthTech · majority shareholder (agreement Dec 2025)
  • Medios
  • alphacaps
  • Coutot-Roehrig
  • MTWH
  • Technotrans
  • SüssMicroTec
  • Sogetrel
  • SNP Schneider-Neureither & Partner
  • Salice
  • Rimed
  • Rattay Group
  • Quip GmbH
  • Pflegebutler
  • Nexus
  • Kestrel Vision
  • iMGP
  • IHS Towers
  • Foyer
  • Evariste
  • ESG Elektroniksystem- und Logistik-GmbH
  • Campings (AddGuests)
  • Atenor
  • Ascom
  • AEB

People

  • Felix Baumann
    Investment Director · source
  • John Penning
    Managing Director (succession process launched Feb 2026) · source
  • François Gillet
    Non-Executive Chairman · source
  • Jacquot Schwertzer
    Vice Chairman · source
  • Owen Tesch
    Non-executive Director · source
  • Xavier Coirbay
    Non-executive Director · source
  • Grégoire Chertok
    Independent Director · source
  • Valentin Cogels
    Independent Director · source
  • Andrea Davis
    Independent Director · source
  • Frank Donck
    Independent Director · source
  • Madeleine Jahr
    Independent Director · source
  • Jürgen Vanselow
    Independent Director · source
  • Rudolf Ohnesorge
    Group Executive Committee member · source
  • Joy Verlé
    Head of France, Group Executive Committee member · source
  • Laurent Zandona
    Partner · source
  • Jean-Philippe Kamm
    Principal · source
  • Philippe Theisen
    Principal · source

Classification

Family Holding. A family's holding company that owns stakes in several separate businesses or invests beyond its own group, without calling itself a family office. How family capital is classified →

FAQ

Luxempart is a family holding based in Leudelange, Luxembourg, founded in 1988.

Luxempart invests directly in companies and in third-party funds as an LP. Its stated asset mix includes private equity, public equities, funds (as lp) and direct investments.

Luxempart invests at Growth and Buyout stages in Fintech, HealthTech and Industrial & Manufacturing.

Luxempart's stated ticket size is €25M–€100M.

Key people at Luxempart include John Penning (Managing Director (succession process launched Feb 2026)), François Gillet (Non-Executive Chairman), Jacquot Schwertzer (Vice Chairman) and Owen Tesch (Non-executive Director).

Luxempart's holdings and investments include Valeara, Medios, alphacaps, Coutot-Roehrig, MTWH, Tonies, Technotrans and SüssMicroTec, among others.

The most recent publicly reported investment by Luxempart is VALEARA (majority stake (investment agreement)), announced in Dec 2025.

No. Luxempart invests its own capital and does not raise money from outside investors.